New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Lonza acquires DHA-business from Nutrinova, a subsidiary of Celanese Corporation

Basel, 19.12.2005 - Lonza has acquired Nutrinova’s DHA business including know-how, patents and registrations in the major global markets. DHA (Docosahexaenoic acid) is a fermentation based health ingredient derived entirely from natural microalgae. It is one of the most important Omega-3 polyunsaturated fatty acids. Numerous scientific as well as clinical studies have demonstrated positive health effects of DHA in particular, in the areas of heart health and brain function. Due to its vegetarian source and superior sensory properties relative to fish oil, DHA has broad applications in the dietary supplements, functional foods and beverages and speciality sectors. Nutrinova DHA has suceesfully been introduced in numerous foods and supplements around the world during the past two years.

With the acquisition of DHA, Lonza expands its portfolio of nutrition businesses within Organic Fine & Performance Chemicals with a health ingredient already well recognized by educated consumer groups. The proprietary fermentation technology of the acquired DHA business provides exclusive access to a unique production strain. Lonza’s process development excellence and manufacturing expertise combined with the ability to become a leading provider of DHA will significantly enhance the value of this business for our customers.

The DHA-business is synergistic with the current L-Carnitine and Niacin franchises of Lonza and will further strengthen the existing distribution channels worldwide. With this acquisition a first important strategy milestone has been completed.
Nutrinova’s superior DHA technology, talented workforce and experience in biotechnology and the food & beverage and health care markets make it an excellent complement.

About Lonza
Lonza, a chemical and biotechnology company driven by the life sciences, generated sales of CHF 2.18 billion in 2004. Headquartered in Switzerland, Lonza operates 18 production and R&D sites around the world. Its 5700 employees are passionately committed to delivering sustainable value to their customers. Lonza is one of the leading custom manufacturers of chemical intermediates, active ingredients and biopharmaceuticals for the pharmaceutical and agrochemical industries. On the basis of organic chemical, oleochemical and biotechnology platforms, Lonza creates value-added solutions for the nutrition, hygiene & personal care, wood & water treatment and industrial specialty markets. Lonza also offers polymer intermediates, resins and compounds. Further information can be found on our website

About Nutrinova
Nutrinova, a subsidiary of Celanese Corporation, is a globally operating supplier of food ingredients and specialtlies for the food, beverage and pharmaceutical industry. With more than 243 employees, more than a dozen affiliates and a strong sales network in all major markets, Nutrinova is a leading expert and partner for sweetening and food protection. Further information can be found on our website

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.